Overview

Blood Levels of Abacavir in HIV Infected Adolescents

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The way abacavir (ABC) behaves in the body differs between children and adults, but little is known about ABC in adolescents. It is unclear if adult doses of ABC are appropriate for adolescents. The purpose of this study is to determine the blood levels of ABC in HIV infected adolescents who are on ABC-containing regimens.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Abacavir
Dideoxynucleosides
Lamivudine
Zidovudine